Fields- Workshop on Statistical Issues in Biomarker and Drug Co-development
-
Title: Biomarker Data 101
Speaker:
Link:
-
Title: Introduction to Microarray Data
Speaker:
Link:
-
Title: Reporting and Evaluation of Studies of Biomarkers and Omics-based Predictors: the REMARK Guidelines and the NCI Omics Checklist
Speaker:
Link:
-
Title: Extensions of BRB-Array Tools
Speaker:
Link:
-
Title: Randomized Phase III Clinical Trial Designs for Targeted Therapies
Speaker:
Link:
-
Title: Statistical Methods in Early Drug Development of Targeted Therapies: A Day in the Life of an Industry Statistician
Speaker:
Link:
-
Title: Prognostic and Predictive Markers: What’s the Difference and why should I care?
Speaker:
Link:
-
Title: Some experience with biomarker driven cancer clinical trials
Speaker:
Link:
-
Title: Imagine… the quest for clinically useful imaging biomarkers
Speaker:
Link:
-
Title: Pharmacogenomics of Aromatase Inhibitors with musculoskeletal adverse events and bone fractures phenotypes
Speaker:
Link:
-
Title: Case-base sampling for fitting and validating prognostic models
Speaker:
Link:
-
Title: Predictive gene signature selection for chemotherapy in early stage non-small cell lung cancer patients
Speaker:
Link:
-
Title: Variable selection and the assessment of predictive accuracy with interval-censored responses
Speaker:
Link: